Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0119 | 0.5834 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0197 | 0.0197 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.0197 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0056 | 0.2218 | 0.3801 |
Echinococcus multilocularis | geminin | 0.0191 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1191 | 0.2042 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0197 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0072 | 0.3096 | 0.5306 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3096 | 0.3096 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0072 | 0.3096 | 0.5306 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0197 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0197 | 0.5 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0197 | 0.5 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0021 | 0.0197 | 0.0197 |
Echinococcus granulosus | tar DNA binding protein | 0.0072 | 0.3096 | 0.3096 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0197 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3096 | 0.3096 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0056 | 0.2218 | 0.3801 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0197 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0072 | 0.3096 | 0.5306 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0.0197 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1191 | 0.1191 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0056 | 0.2218 | 0.3801 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.0197 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0072 | 0.3096 | 0.3096 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0119 | 0.5834 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3096 | 0.3096 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0021 | 0.0197 | 0.0197 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.1191 | 0.2042 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.0197 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0197 | 0.0197 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.2218 | 0.3801 |
Schistosoma mansoni | hypothetical protein | 0.0191 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0119 | 0.5834 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.0197 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3096 | 0.3096 |
Brugia malayi | RNA binding protein | 0.0072 | 0.3096 | 0.5306 |
Loa Loa (eye worm) | TAR-binding protein | 0.0072 | 0.3096 | 0.5306 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.0197 | 0.0338 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3096 | 0.3096 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.0197 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0197 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0072 | 0.3096 | 0.5306 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.0197 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.0197 | 0.5 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.0197 | 0.0338 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.